These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8649521)
21. The diagnosis and treatment of deep-vein thrombosis. Verstraete M N Engl J Med; 1993 Nov; 329(19):1418-20. PubMed ID: 8413441 [No Abstract] [Full Text] [Related]
22. [The future of low molecular weight heparins in the curative treatment of deep venous thrombosis]. St-Louis J; St-Louis JM Union Med Can; 1994 Mar; 123(3):147-51. PubMed ID: 8184510 [No Abstract] [Full Text] [Related]
27. [Heparin after deep venous thrombosis. Even the first injection the patient can administer himself]. MMW Fortschr Med; 1999 Dec; 141(51-52):62. PubMed ID: 10949629 [No Abstract] [Full Text] [Related]
28. Home treatment and secondary prevention of deep vein thrombosis. Prandoni P; Mosena L Haematologica; 2001 Nov; 86(11 Suppl 2):49-53. PubMed ID: 11926778 [No Abstract] [Full Text] [Related]
31. Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin. Dobie SA; Ellsworth AJ; Linenberger ML West J Med; 1996 Apr; 164(4):350-3. PubMed ID: 8732743 [No Abstract] [Full Text] [Related]
32. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination. Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067 [TBL] [Abstract][Full Text] [Related]
33. [In recent studies patients with deep venous thrombosis (popliteal vein, femoral vein) were treated on an ambulatory basis with low molecular weight heparin (without immobilization!)]. Wagner T Internist (Berl); 1996 Sep; 37(9):943. PubMed ID: 8964693 [No Abstract] [Full Text] [Related]
34. Diagnostic and therapeutic management of patients with deep-vein thrombosis: coming to maturity? Büller HR; Koopman MM Neth J Med; 1996 Mar; 48(3):81-4. PubMed ID: 8935746 [No Abstract] [Full Text] [Related]
35. Outpatient treatment of deep vein thrombosis with LMWH. Koopman MM Wien Med Wochenschr; 1999; 149(2-4):46-9; discussion 49. PubMed ID: 10378322 [TBL] [Abstract][Full Text] [Related]
36. Clinical experiences in the administration of a low molecular weight heparin (Fragmin, Kabi-Vitrum) to healthy volunteers and in the treatment of established deep venous thrombosis. Bratt GA; Törnebohm E; Johanson M; Aberg W; Granqvist S; Lockner D Acta Chir Scand Suppl; 1988; 543():96-100. PubMed ID: 2847465 [TBL] [Abstract][Full Text] [Related]
37. Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results. Crowther M; Hirsh J Semin Thromb Hemost; 1997; 23(1):77-81. PubMed ID: 9156414 [TBL] [Abstract][Full Text] [Related]
38. Low-molecular-weight heparins allow selected outpatient treatment for venous thrombosis. Veller M; Louridas G; Levien L S Afr Med J; 1998 Jun; 88(6):694-5. PubMed ID: 9687845 [No Abstract] [Full Text] [Related]
39. When can the patient with deep venous thrombosis begin to ambulate? Aldrich D; Hunt DP Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299 [No Abstract] [Full Text] [Related]
40. [Thrombophlebitis of the leg: diagnosis and treatment by the general practitioner]. Timmermans SH; Wlazlo N; Mom EM; Stoffers HE Ned Tijdschr Geneeskd; 2010; 154():A1098. PubMed ID: 20178665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]